The United States Food and DrugAdministration (FDA) have thus far approved two categories of medications for the treatment of AD: Acetylcholinesterase inhibitors andN-methyl-D-aspartate (NMDA) receptor antagonists [2]. Here, ACHE is linked to Alzheimer disease.